Treatment of Rickettsia spp. infections: a review

References

• Dumler JS, Barbet AF, Bekker CP et al. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and ‘HGE agent’ as subjective synonyms of Ehrlichia phagocytophila. Int. J. Syst. Evol. Microbiol. 51(Pt 6), 2145–2165 (2001).
   PubMed Web of Science ®Google Scholar
• Watt G, Parola P. Scrub typhus and tropical rickettsioses. Curr. Opin. Infect. Dis. 16(5), 429–436 (2003).
   PubMed Web of Science ®Google Scholar
• Parola P, Paddock CD, Raoult D. Tick-borne rickettsioses around the world: emerging diseases challenging old concepts. Clin. Microbiol. Rev. 18(4), 719–756 (2005).
   PubMed Web of Science ®Google Scholar
• Dumler JS, Madigan JE, Pusterla N, Bakken JS. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin. Infect. Dis. 45(Suppl. 1), S45–S51 (2007).
   PubMed Web of Science ®Google Scholar
• Chapman AS, Bakken JS, Folk SM et al.; Tickborne Rickettsial Diseases Working Group; CDC. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis – United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm. Rep. 55(RR-4), 1–27 (2006).
   Google Scholar
• Rajapakse S, Rodrigo C, Fernando SD. Drug treatment of scrub typhus. Trop. Doct. 41(1), 1–4 (2011).
   PubMed Web of Science ®Google Scholar
• Botelho-Nevers E, Raoult D. Host, pathogen and treatment-related prognostic factors in rickettsioses. Eur. J. Clin. Microbiol. Infect. Dis. 30(10), 1139–1150 (2011).
   PubMedGoogle Scholar
• Raoult D, Roussellier P, Galicher V, Perez R, Tamalet J. In vitro susceptibility of Rickettsia conorii to ciprofloxacin as determined by suppressing lethality in chicken embryos and by plaque assay. Antimicrob. Agents Chemother. 29(3), 424–425 (1986).
   PubMedGoogle Scholar
• Rolain JM, Maurin M, Vestris G, Raoult D. In vitro susceptibilities of 27 rickettsiae to 13 antimicrobials. Antimicrob. Agents Chemother. 42(7), 1537–1541 (1998).
   PubMed Web of Science ®Google Scholar
• Rolain JM, Raoult D. Antimicrobial susceptibility testing for some atypical microorganisms (Chlamydia, Mycoplasma, Rickettsia, Ehrlichia, Coxiella and Spirochetes). Antibiotics in Laboratory Medicine. In: Victor L (Ed.). Lippincott Williams & Wilkins, NY, USA, 266–288 (2005).
   Google Scholar
• Rolain JM, Stuhl L, Maurin M, Raoult D. Evaluation of antibiotic susceptibilities of three rickettsial species including Rickettsia felis by a quantitative PCR DNA assay. Antimicrob. Agents Chemother. 46(9), 2747–2751 (2002).
   PubMed Web of Science ®Google Scholar
• Parola P, Davoust B, Raoult D. Tick- and flea-borne rickettsial emerging zoonoses. Vet. Res. 36(3), 469–492 (2005).
   PubMed Web of Science ®Google Scholar
• Parola P, Raoult D. Ticks and tickborne bacterial diseases in humans: an emerging infectious threat. Clin. Infect. Dis. 32(6), 897–928 (2001).
   PubMed Web of Science ®Google Scholar
• Jensenius M, Fournier PE, Raoult D. Rickettsioses and the international traveler. Clin. Infect. Dis. 39(10), 1493–1499 (2004).
   PubMedGoogle Scholar
• Socolovschi C, Bitam I, Raoult D, Parola P. Transmission of Rickettsia conorii conorii in naturally infected Rhipicephalus sanguineus. Clin. Microbiol. Infect. 15(Suppl. 2), 319–321 (2009).
   PubMedGoogle Scholar
• Botelho-Nevers E, Rovery C, Richet H, Raoult D. Analysis of risk factors for malignant Mediterranean spotted fever indicates that fluoroquinolone treatment has a deleterious effect. J. Antimicrob. Chemother. 66(8), 1821–1830 (2011).
   PubMedGoogle Scholar
• Colomba C, Saporito L, Siracusa L, Giammanco G, Bonura S, Titone L. [Mediterranean spotted fever in paediatric and adult patients: two clinical aspects of the same disease]. Infez. Med. 19(4), 248–253 (2011).
   PubMedGoogle Scholar
• Raoult D, Roussellier P, Vestris G, Tamalet J. In vitro antibiotic susceptibility of Rickettsia rickettsii and Rickettsia conorii: plaque assay and microplaque colorimetric assay. J. Infect. Dis. 155(5), 1059–1062 (1987).
   PubMedGoogle Scholar
• Raoult D, Roussellier P, Tamalet J. In vitro evaluation of josamycin, spiramycin, and erythromycin against Rickettsia rickettsii and R. conorii. Antimicrob. Agents Chemother. 32(2), 255–256 (1988).
   PubMedGoogle Scholar
• Rolain JM, Raoult D. Prediction of resistance to erythromycin in the genus Rickettsia by mutations in L22 ribosomal protein. J. Antimicrob. Chemother. 56(2), 396–398 (2005).
   PubMedGoogle Scholar
• Ives TJ, Manzewitsch P, Regnery RL, Butts JD, Kebede M. In vitro susceptibilities of Bartonella henselae, B. quintana, B. elizabethae, Rickettsia rickettsii, R. conorii, R. akari, and R. prowazekii to macrolide antibiotics as determined by immunofluorescent-antibody analysis of infected Vero cell monolayers. Antimicrob. Agents Chemother. 41(3), 578–582 (1997).
   PubMedGoogle Scholar
• Maurin M, Raoult D. In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin. Antimicrob. Agents Chemother. 37(12), 2633–2637 (1993).
   PubMed Web of Science ®Google Scholar
• Drancourt M, Raoult D. In vitro susceptibilities of Rickettsia rickettsii and Rickettsia conorii to roxithromycin and pristinamycin. Antimicrob. Agents Chemother. 33(12), 2146–2148 (1989).
   PubMedGoogle Scholar
• Rolain JM, Maurin M, Bryskier A, Raoult D. In vitro activities of telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, and Ehrlichia chaffeensis. Antimicrob. Agents Chemother. 44(5), 1391–1393 (2000).
   PubMed Web of Science ®Google Scholar
• Raoult D, Roussellier P, Vestris G, Galicher V, Perez R, Tamalet J. Susceptibility of Rickettsia conorii and R. rickettsii to pefloxacin, in vitro and in ovo. J. Antimicrob. Chemother. 19(3), 303–305 (1987).
   PubMedGoogle Scholar
• Jabarit-Aldighieri N, Torres H, Raoult D. Susceptibility of Rickettsia conorii, R. rickettsii, and Coxiella burnetii to PD 127,391, PD 131,628, pefloxacin, ofloxacin, and ciprofloxacin. Antimicrob. Agents Chemother. 36(11), 2529–2532 (1992).
   PubMedGoogle Scholar
• Maurin M, Raoult D. Bacteriostatic and bactericidal activity of levofloxacin against Rickettsia rickettsii, Rickettsia conorii, ‘Israeli spotted fever group rickettsia’ and Coxiella burnetii. J. Antimicrob. Chemother. 39(6), 725–730 (1997).
   PubMedGoogle Scholar
• Botelho-Nevers E, Edouard S, Leroy Q, Raoult D. Deleterious effect of ciprofloxacin on Rickettsia conorii-infected cells is linked to toxin-antitoxin module up-regulation. J. Antimicrob. Chemother. 67(7), 1677–1682 (2012).
   PubMedGoogle Scholar
• Bella-Cueto F, Font-Creus B, Segura-Porta F, Espejo-Arenas E, López-Parés P, Muñoz-Espín T. Comparative, randomized trial of one-day doxycycline versus 10-day tetracycline therapy for Mediterranean spotted fever. J. Infect. Dis. 155(5), 1056–1058 (1987).
   PubMedGoogle Scholar
• Lochary ME, Lockhart PB, Williams WT Jr. Doxycycline and staining of permanent teeth. Pediatr. Infect. Dis. J. 17(5), 429–431 (1998).
   PubMed Web of Science ®Google Scholar
• Cascio A, Di Liberto C, D’Angelo M et al. No findings of dental defects in children treated with minocycline. Antimicrob. Agents Chemother. 48(7), 2739–2741 (2004).
   PubMedGoogle Scholar
• Smilack JD. The tetracyclines. Mayo Clin. Proc. 74(7), 727–729 (1999).
   PubMed Web of Science ®Google Scholar
• Shaked Y, Samra Y, Maier MK, Rubinstein E. Relapse of rickettsial Mediterranean spotted fever and murine typhus after treatment with chloramphenicol. J. Infect. 18(1), 35–37 (1989).
   PubMedGoogle Scholar
• Ruiz Beltrán R, Herrero Herrero JI. Evaluation of ciprofloxacin and doxycycline in the treatment of Mediterranean spotted fever. Eur. J. Clin. Microbiol. Infect. Dis. 11(5), 427–431 (1992).
   PubMedGoogle Scholar
• Raoult D, Gallais H, De Micco P, Casanova P. Ciprofloxacin therapy for Mediterranean spotted fever. Antimicrob. Agents Chemother. 30(4), 606–607 (1986).
   PubMedGoogle Scholar
• Gudiol F, Pallares R, Carratala J et al. Randomized double-blind evaluation of ciprofloxacin and doxycycline for Mediterranean spotted fever. Antimicrob. Agents Chemother. 33(6), 987–988 (1989).
   PubMedGoogle Scholar
• Cascio A, Colomba C, Di Rosa D, Salsa L, di Martino L, Titone L. Efficacy and safety of clarithromycin as treatment for Mediterranean spotted fever in children: a randomized controlled trial. Clin. Infect. Dis. 33(3), 409–411 (2001).
   PubMed Web of Science ®Google Scholar
• Cascio A, Colomba C, Antinori S, Paterson DL, Titone L. Clarithromycin versus azithromycin in the treatment of Mediterranean spotted fever in children: a randomized controlled trial. Clin. Infect. Dis. 34(2), 154–158 (2002).
   PubMed Web of Science ®Google Scholar
• Bella F, Font B, Uriz S et al. Randomized trial of doxycycline versus josamycin for Mediterranean spotted fever. Antimicrob. Agents Chemother. 34(5), 937–938 (1990).
   PubMedGoogle Scholar
• Meloni G, Meloni T. Azithromycin vs. doxycycline for Mediterranean spotted fever. Pediatr. Infect. Dis. J. 15(11), 1042–1044 (1996).
   PubMedGoogle Scholar
• Muñoz-Espin T, López-Parés P, Espejo-Arenas E et al. Erythromycin versus tetracycline for treatment of Mediterranean spotted fever. Arch. Dis. Child. 61(10), 1027–1029 (1986).
   PubMedGoogle Scholar
• Ruiz Beltrán R, Herrero Herrero JI. Deleterious effect of trimethoprim-sulfamethoxazole in Mediterranean spotted fever. Antimicrob. Agents Chemother. 36(6), 1342–1343 (1992).
   PubMed Web of Science ®Google Scholar
• de Sousa R, Nóbrega SD, Bacellar F, Torgal J. Mediterranean spotted fever in Portugal: risk factors for fatal outcome in 105 hospitalized patients. Ann. NY Acad. Sci. 990, 285–294 (2003).
   PubMed Web of Science ®Google Scholar
• Bella F, Espejo E, Uriz S, Serrano JA, Alegre MD, Tort J. Randomized trial of 5-day rifampin versus 1-day doxycycline therapy for Mediterranean spotted fever. J. Infect. Dis. 164(2), 433–434 (1991).
   PubMedGoogle Scholar
• Openshaw JJ, Swerdlow DL, Krebs JW et al. Rocky mountain spotted fever in the United States, 2000-2007: interpreting contemporary increases in incidence. Am. J. Trop. Med. Hyg. 83(1), 174–182 (2010).
   PubMedGoogle Scholar
• Sexton DJ, Walker DH. Spotted fever group rickettsioses. Tropical Infectious Diseases: Principles, Pathogens, and Practice. In: Guerrant RL, Walker H, Weller PF (Eds). Saunders Elsevier, NY, USA, 323–329 (2011).
   Google Scholar
• Walker DH, Sexton DJ. Rickettsia rickettsii (Rocky Mountain spotted fever). Antimicrobial Therapy and Vaccines. In: Yu V, Weber R, Raoult D (Eds). Apple Trees Productions, LLC, NY, USA, 899–906 (2002).
   Google Scholar
• Wisseman CL, Waddell A. In vitro sensitivity of Rickettsia rickettsii to doxycycline. J. Infect. Dis. 145(4), 584 (1982).
   PubMedGoogle Scholar
• Breitschwerdt EB, Papich MG, Hegarty BC, Gilger B, Hancock SI, Davidson MG. Efficacy of doxycycline, azithromycin, or trovafloxacin for treatment of experimental Rocky Mountain spotted fever in dogs. Antimicrob. Agents Chemother. 43(4), 813–821 (1999).
   PubMedGoogle Scholar
• Holman RC, Paddock CD, Curns AT, Krebs JW, McQuiston JH, Childs JE. Analysis of risk factors for fatal Rocky Mountain spotted fever: evidence for superiority of tetracyclines for therapy. J. Infect. Dis. 184(11), 1437–1444 (2001).
   PubMedGoogle Scholar
• Dalton MJ, Clarke MJ, Holman RC et al. National surveillance for Rocky Mountain spotted fever, 1981–1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am. J. Trop. Med. Hyg. 52(5), 405–413 (1995).
   PubMedGoogle Scholar
• Fishbein DB, Frontini MG, Giles R, Vernon LL. Fatal cases of Rocky Mountain spotted fever in the United States, 1981–1988. Ann. NY Acad. Sci. 590, 246–247 (1990).
   PubMedGoogle Scholar
• Breitschwerdt EB, Davidson MG, Hegarty BC, Papich MG, Grindem CB. Prednisolone at anti-inflammatory or immunosuppressive dosages in conjunction with doxycycline does not potentiate the severity of Rickettsia rickettsii infection in dogs. Antimicrob. Agents Chemother. 41(1), 141–147 (1997).
   PubMedGoogle Scholar
• Audoly G, Vincentelli R, Edouard S et al. Effect of rickettsial toxin VapC on its eukaryotic host. PLoS ONE 6(10), e26528 (2011).
   PubMedGoogle Scholar
• Nakamura T, Takagaki K, Matsubara Y, Kikuchi K. Predictive values of clinical parameters for severe Japanese spotted fever. J. Infect. Chemother. 17(2), 246–253 (2011).
   PubMedGoogle Scholar
• Nomura T, Fujimoto T, Ebisutani C, Horiguchi H, Ando S. The first fatal case of Japanese spotted fever confirmed by serological and microbiological tests in Awaji Island, Japan. Infect. Dis. 60(4), 241–243 (2007).
   Google Scholar
• Wada K, Sakaeda H, Aono R, Chiya S. [Fulminant Japanese spotted fever – the second fatal case in Japan]. Kansenshogaku Zasshi. 82(2), 77–81 (2008).
   PubMedGoogle Scholar
• Seki M, Ikari N, Yamamoto S et al. Severe Japanese spotted fever successfully treated with fluoroquinolone. Intern. Med. 45(22), 1323–1326 (2006).
   PubMed Web of Science ®Google Scholar
• Roch N, Epaulard O, Pelloux I et al. African tick bite fever in elderly patients: 8 cases in French tourists returning from South Africa. Clin. Infect. Dis. 47(3), e28–e35 (2008).
   PubMedGoogle Scholar
• Jensenius M, Fournier PE, Kelly P, Myrvang B, Raoult D. African tick bite fever. Lancet Infect. Dis. 3(9), 557–564 (2003).
   PubMed Web of Science ®Google Scholar
• Méchaï F, Han Y, Gachot B et al. Pristinamycin for Rickettsia africae infection. J. Travel Med. 16(2), 136–137 (2009).
   PubMedGoogle Scholar
• Paddock CD, Finley RW, Wright CS et al. Rickettsia parkeri rickettsiosis and its clinical distinction from Rocky Mountain spotted fever. Clin. Infect. Dis. 47(9), 1188–1196 (2008).
   PubMed Web of Science ®Google Scholar
• Walker DH, Raoult D. Typhus group rickettsioses. Tropical Infectious Diseases: Principles, Pathogens, and Practice. In: Guerrant RL, Walker DH, Weller PF (Eds). Saunders Elsevier, NY, USA, 329–334 (2011).
   Google Scholar
• Dumler JS, Taylor JP, Walker DH. Clinical and laboratory features of murine typhus in south Texas, 1980 through 1987. JAMA 266(10), 1365–1370 (1991).
   PubMed Web of Science ®Google Scholar
• Walter G, Botelho-Nevers E, Socolovschi C et al. Murine typhus in returned travelers: a report of thirty-two cases. Am. J. Trop. Med. Hyg. 86(6), 1049–1053 (2012).
   PubMedGoogle Scholar
• Botelho-Nevers E, Raoult D. Fever of unknown origin due to rickettsioses. Infect. Dis. Clin. North Am. 21(4), 997–1011, ix (2007).
   PubMedGoogle Scholar
• Rolain JM, Raoult D. Genome comparison analysis of molecular mechanisms of resistance to antibiotics in the Rickettsia genus. Ann. NY Acad. Sci. 1063, 222–230 (2005).
   PubMedGoogle Scholar
• Strand O, Strömberg A. Ciprofloxacin treatment of murine typhus. Scand. J. Infect. Dis. 22(4), 503–504 (1990).
   PubMed Web of Science ®Google Scholar
• Eaton M, Cohen MT, Shlim DR, Innes B. Ciprofloxacin treatment of typhus. JAMA 262(6), 772–773 (1989).
   PubMed Web of Science ®Google Scholar
• Laferl H, Fournier PE, Seiberl G, Pichler H, Raoult D. Murine typhus poorly responsive to ciprofloxacin: a case report. J. Travel Med. 9(2), 103–104 (2002).
   PubMedGoogle Scholar
• Van Der Kleij FG, Gansevoort RT, Kreeftenberg HG, Reitsma WD. Imported rickettsioses: think of murine typhus. J. Intern. Med. 243(2), 177–179 (1998).
   PubMedGoogle Scholar
• Koliou M, Christoforou C, Soteriades ES. Murine typhus in pregnancy: a case report from Cyprus Scand. J. Infect. Dis. 39(6–7), 625–628 (2007).
   PubMed Web of Science ®Google Scholar
• Merhej V, Raoult D. Rickettsial evolution in the light of comparative genomics. Biol. Rev. Camb. Philos. Soc. 86(2), 379–405 (2011).
   PubMed Web of Science ®Google Scholar
• Merhej V, Notredame C, Royer-Carenzi M, Pontarotti P, Raoult D. The rhizome of life: the sympatric Rickettsia felis paradigm demonstrates the random transfer of DNA sequences. Mol. Biol. Evol. 28(11), 3213–3223 (2011).
   PubMedGoogle Scholar
• Parola P. Rickettsia felis: from a rare disease in the USA to a common cause of fever in sub-Saharan Africa. Clin. Microbiol. Infect. 17(7), 996–1000 (2011).
   PubMed Web of Science ®Google Scholar
• Socolovschi C, Mediannikov O, Sokhna C et al. Rickettsia felis-associated uneruptive fever, Senegal. Emerging Infect. Dis. 16(7), 1140–1142 (2010).
   PubMed Web of Science ®Google Scholar
• Faucher JF, Socolovschi C, Aubry C et al. Brill-Zinsser disease in Moroccan man, France, 2011. Emerging Infect. Dis. 18(1), 171–172 (2012).
   PubMedGoogle Scholar
• Bechah Y, Capo C, Mege JL, Raoult D. Rickettsial diseases: from Rickettsia-arthropod relationships to pathophysiology and animal models. Future Microbiol. 3(2), 223–236 (2008).
   PubMedGoogle Scholar
• Wisseman CL Jr, Waddell AD, Walsh WT. In vitro studies of the action of antibiotics on Rickettsia prowazeki by two basic methods of cell culture. J. Infect. Dis. 130(6), 564–574 (1974).
   PubMedGoogle Scholar
• Weiss E, Dressler HR. Selection of an erythromycin-resistant strain of Rickettsia prowazekii. Am. J. Hyg. 71, 292–298 (1960).
   PubMedGoogle Scholar
• Ives TJ, Marston EL, Regnery RL, Butts JD. In vitro susceptibilities of Bartonella and Rickettsia spp. to fluoroquinolone antibiotics as determined by immunofluorescent antibody analysis of infected Vero cell monolayers. Int. J. Antimicrob. Agents 18(3), 217–222 (2001).
   PubMedGoogle Scholar
• Huys J, Kayhigi J, Freyens P, Berghe GV. Single-dose treatment of epidemic typhus with doxycyline. Chemotherapy 18(5), 314–317 (1973).
   PubMedGoogle Scholar
• Raoult D, Ndihokubwayo JB, Tissot-Dupont H et al. Outbreak of epidemic typhus associated with trench fever in Burundi. Lancet 352(9125), 353–358 (1998).
   PubMedGoogle Scholar
• Huys J, Freyens P, Kayihigi J, Van den Berghe G. Treatment of epidemic typhus. A comparative study of chloramphenicol, trimethoprim-sulphamethoxazole and doxycycline. Trans. R. Soc. Trop. Med. Hyg. 67(5), 718–721 (1973).
   PubMedGoogle Scholar
• Zanetti G, Francioli P, Tagan D, Paddock CD, Zaki SR. Imported epidemic typhus. Lancet 352(9141), 1709 (1998).
   PubMed Web of Science ®Google Scholar
• Turcinov D, Kuzman I, Herendic B. Failure of azithromycin in treatment of Brill–Zinsser disease. Antimicrob. Agents Chemother. 44(6), 1737–1738 (2000).
   PubMedGoogle Scholar
• Raoult D, Maurin M. Rickettsia akari (rickettsialpox). In: Antimicrobial Therapy and Vaccines. Yu V, Weber R, Raoult D (Eds). Apple Trees Productions, LLC, NY, USA, 889–892 (2002).
   Google Scholar
• La Scola B, Raoult D. Laboratory diagnosis of rickettsioses: current approaches to diagnosis of old and new rickettsial diseases. J. Clin. Microbiol. 35(11), 2715–2727 (1997).
   PubMed Web of Science ®Google Scholar
• Richards AL. Worldwide detection and identification of new and old rickettsiae and rickettsial diseases. FEMS Immunol. Med. Microbiol. 64(1), 107–110 (2012).
   PubMedGoogle Scholar
• Bechah Y, Socolovschi C, Raoult D. Identification of rickettsial infections by using cutaneous swab specimens and PCR. Emerging Infect. Dis. 17(1), 83–86 (2011).
   PubMed Web of Science ®Google Scholar
• Botelho-Nevers E, Rolain JM, Espinosa L, Raoult D. Statins limit Rickettsia conorii infection in cells. Int. J. Antimicrob. Agents 32(4), 344–348 (2008).
   PubMedGoogle Scholar
• Jayaseelan E, Rajendran SC, Shariff S, Fishbein D, Keystone JS. Cutaneous eruptions in Indian tick typhus. Int. J. Dermatol. 30(11), 790–794 (1991).
   PubMed Web of Science ®Google Scholar
• Unsworth NB, Stenos J, Graves SR et al. Flinders Island spotted fever rickettsioses caused by “marmionii” strain of Rickettsia honei, Eastern Australia. Emerging Infect. Dis. 13(4), 566–573 (2007).
   PubMedGoogle Scholar
• Parola P, Rovery C, Rolain JM, Brouqui P, Davoust B, Raoult D. rickettsia slovaca and R. raoultii in tick-borne Rickettsioses. Emerging Infect. Dis. 15(7), 1105–1108 (2009).
   PubMed Web of Science ®Google Scholar
• Bechah Y, Capo C, Mege JL, Raoult D. Epidemic typhus. Lancet Infect. Dis. 8(7), 417–426 (2008).
   PubMed Web of Science ®Google Scholar
• Canadian Task Force on the Periodic Health Examination. The periodic health examination. Can. Med. Assoc. J. 121(9), 1193–1254 (1979).
   PubMed Web of Science ®Google Scholar